|
ZA200603682B
|
|
Method
|
|
TW200628611A
|
|
Nucleic acid constructs
|
|
GB0507997D0
|
|
Nucleic acid constructs
|
|
US2005266021A1
|
|
Powder compositions
|
|
AU2004280630A1
|
|
Method
|
|
CN1890375A
|
|
Nucleic acid constructs
|
|
US2004213798A1
|
|
Spray-dried alum compositions
|
|
US2005148529A1
|
|
Nucleic acid immunization
|
|
US2004109874A1
|
|
Induction of mucosal immunity by vaccination via the skin route
|
|
ZA200308825B
|
|
Vaccine composition.
|
|
WO02100380A1
|
|
Production of hard, dense particles
|
|
EP1392357A2
|
|
Vaccine composition
|
|
IL156041D0
|
|
Nucleic acid adjuvants
|
|
EP1392365A2
|
|
Compositions and therapeutical use of polynucleotides encoding tcrs
|
|
WO0193829A2
|
|
Powder compositions
|
|
AU5239001A
|
|
Nucleic acid immunization
|
|
AU1481401A
|
|
Induction of mucosal immunity by vaccination via the skin route
|
|
CA2389693A1
|
|
Dna-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
WO0132204A2
|
|
Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
|
|
US7196066B1
|
|
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
